Vyluma
Pre-clinicalVyluma develops pharmaceutical treatments for progressive myopia in children.
Founded
2020
Focus
Small Molecules
About
Vyluma develops pharmaceutical treatments for progressive myopia in children.
Funding History
2Total raised: $125M
Series B$75MUndisclosedJan 15, 2023
Series A$50MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2020
LocationBridgewater, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile